Aggression"GIRAFFE"NCT07621874
Intensive Care Unit Conflict Mediation Study
A study testing SEM DESTINO in people with Aggression and Critical Care Staff, run by Hospital Israelita Albert Einstein.
Trial summary
To evaluate the impact of a structured, multidisciplinary conflict management program incorporating an interprofessional Singular Care Plan *PAS* Committee and a Conflict Mediation Team on the incidence and severity of conflicts, family satisfaction, and staff well-being in an adult intensive care unit *ICU* Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Aggression, Critical Care Staff, Workplace Violence
- What is being tested?
- SEM DESTINO
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 1 Oct 2026to 1 Aug 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
-family members of patients or intensive care unit staff
About this study
Official title: A Multidisciplinary Framework for ICU Conflict Mediation: Rationale and Methodological Approach to Enhancing Safety and Care Quality
To evaluate the impact of a structured, multidisciplinary conflict management program incorporating an interprofessional Singular Care Plan *PAS* Committee and a Conflict Mediation Team on the incidence and severity of conflicts, family satisfaction, and staff well-being in an adult intensive care unit *ICU*
Read the detailed description
The allocation is non randomized because the intervention is implemented at the level of the intensive care unit and cannot ethically or practically be restricted to a subset of patients or staff. The masking status is open label, as it is not feasible to blind staff or families to the presence of a conflict mediator or the convening of a committee. The primary purpose of the study is health services research, specifically the evaluation of an institutional policy for conflict management and its impact on conflict dynamics, safety and experience in critical care.
- Conditions
- Aggression, Critical Care Staff, Workplace Violence
- Being tested
- SEM DESTINO
- Keywords
- Aggression, critical care, Workplace violence
- Medical subject headings
- Aggression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SEM DESTINOBehavioural
The Conflict Mediation Team is composed of trained facilitators who can be activated by any assistential collaborator when a conflict in progress exceeds the collaborator's capacity to manage it. The Singular Care Plan Committee is convened by the facilitator in complex cases that require broader, interprofessional analysis and the elaboration of a documented care plan based on the SEM DESTINO mnemonic
| Study group | Role | What they receive |
|---|---|---|
| Structured Conflict Management Program | Experimental | All participants will be part of a single arm titled "Structured Conflict Management Program". The intervention is an organizational and behavioral program that introduces a Conflict Mediation Team and a Singular Care Plan Committee in the intensive care unit, grounded in nonviolent communication. The Conflict Mediation Team is composed of trained facilitators who can be activated by any assistential collaborator when a conflict in progress exceeds the collaborator's capacity to manage it. The Singular Care Plan Committee is convened by the facilitator in complex cases that require broader, interprofessional analysis and the elaboration of a documented care plan based on the SEM DESTINO mnemonic. Receives: Behavioral: SEM DESTINO |
What is being measured
The primary outcome is the main question the study is designed to answer.
-conflict index
the rate of significant conflicts per 100 ICU admissions.
Measured: 12 months
Prevalence of post-traumatic stress symptoms in ICU family member
Proportion of ICU family members with post-traumatic stress symptoms, defined as an Impact of Event Scale-6 (IES-6) mean item score > 1.75, assessed 6 months after ICU discharge of the index patient.
Measured: 6 months after ICU discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jun 2026
- Study start1 Oct 2026 (estimated)
- Primary completion1 Aug 2027 (estimated)
- Study completion1 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AggressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital Israelita Albert Einstein
- Sponsor type
- University, hospital or other
- Collaborators
- Instituto D'Or de Pesquisa
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07621874
- Sponsor's protocol ID
- 68567898809090
- Acronym
- "GIRAFFE"
- Status last verified
- May 2026
- First submitted
- 18 May 2026
- Last updated
- 2 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: sensible data HIPPA ACT
Study at a glance
From the registry record, last updated by the sponsor on 2 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Multidisciplinary Framework for ICU Conflict Mediation: Rationale and Methodological Approach to Enhancing Safety and Care Quality
- ClinicalTrials.gov ID
- NCT07621874
- Acronym / sponsor ID
- "GIRAFFE" / 68567898809090
- Conditions
- Aggression, Critical Care Staff, Workplace Violence
- Keywords
- Aggression, critical care, Workplace violence
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Hospital Israelita Albert EinsteinUniversity, hospital or other
- Collaborators
- Instituto D'Or de Pesquisa
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 1 Aug 2027 (estimated)
- Study completion
- 1 Aug 2027 (estimated)
- First posted
- 2 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the impact of a structured, multidisciplinary conflict management program incorporating an interprofessional Singular Care Plan *PAS* Committee and a Conflict Mediation Team on the incidence and severity of conflicts, family satisfaction, and staff well-being in an adult intensive care unit *ICU*
Detailed description
The allocation is non randomized because the intervention is implemented at the level of the intensive care unit and cannot ethically or practically be restricted to a subset of patients or staff. The masking status is open label, as it is not feasible to blind staff or families to the presence of a conflict mediator or the convening of a committee. The primary purpose of the study is health services research, specifically the evaluation of an institutional policy for conflict management and its impact on conflict dynamics, safety and experience in critical care.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Structured Conflict Management Program | Experimental | Behavioral: SEM DESTINOAll participants will be part of a single arm titled "Structured Conflict Management Program". The intervention is an organizational and behavioral program that introduces a Conflict Mediation Team and a Singular Care Plan Committee in the intensive care unit, grounded in nonviolent communication. The Conflict Mediation Team is composed of trained facilitators who can be activated by any assistential collaborator when a conflict in progress exceeds the collaborator's capacity to manage it. The Singular Care Plan Committee is convened by the facilitator in complex cases that require broader, interprofessional analysis and the elaboration of a documented care plan based on the SEM DESTINO mnemonic. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SEM DESTINOThe Conflict Mediation Team is composed of trained facilitators who can be activated by any assistential collaborator when a conflict in progress exceeds the collaborator's capacity to manage it. The Singular Care Plan Committee is convened by the facilitator in complex cases that require broader, interprofessional analysis and the elaboration of a documented care plan based on the SEM DESTINO mnemonic | Behavioural | Structured Conflict Management Program |
Primary outcome
-conflict index
Time frame: 12 months
the rate of significant conflicts per 100 ICU admissions.
Prevalence of post-traumatic stress symptoms in ICU family member
Time frame: 6 months after ICU discharge
Proportion of ICU family members with post-traumatic stress symptoms, defined as an Impact of Event Scale-6 (IES-6) mean item score > 1.75, assessed 6 months after ICU discharge of the index patient.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jun 2026.
- Individual participant dataSharing planned: No. sensible data HIPPA ACT
Related trials for Aggression
Recruiting
Virtual Reality Intervention (VR-GINSO) for Reducing Aggression in Young Offenders
Aggression
Not yet recruiting
Virtual Reality to Advance Dementia Care and Quality of Life
Dementia, Agitation
Active, not recruiting
Manage Emotions to Reduce Aggression (MERA)
Stress Disorders, Post-Traumatic, Aggression
Recruiting
Momentary Coping Prompts and Hair Steroids in College Students
Emotional Regulation, Alcohol Drinking in College
Recruiting
Just-in-Time Coping Prompts for Reactive Digital Behavior in College Students
Emotional Regulation, Alcohol Drinking in College
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing SEM DESTINO in people with Aggression and Critical Care Staff, run by Hospital Israelita Albert Einstein.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
-conflict index (time frame: 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026; AzTrials last refreshed its copy on 28 Oct 2026.